+ All Categories
Home > Documents > HIV and Pregnancy Prevention of Mother-To-Child Transmission

HIV and Pregnancy Prevention of Mother-To-Child Transmission

Date post: 03-Jun-2018
Category:
Upload: susan-hepzi
View: 219 times
Download: 0 times
Share this document with a friend

of 29

Transcript
  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    1/29

    HIV and Pregnancy: Prevention of

    Mother-to-Child Transmission

    Advances in Maternal and Neonatal Health

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    2/29

    2HIV and Pregnancy

    Session Objectives

    To discuss best practice for antenatal, intrapartum andpostpartum care of the HIV-positive mother to reduce mother-to-child transmission

    To review the evidence supporting these practices

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    3/29

    3HIV and Pregnancy

    HIV-Related Counseling Issues

    During PregnancyEducate/counsel regarding HIV and pregnancy beforepregnancy:

    Impact of HIV on pregnancy and pregnancy on HIV

    Maternal health

    Long-term health of mother and care for children

    Perinatal transmission

    Use of antiretrovirals and other drugs in pregnancy

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    4/29

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    5/29

    5HIV and Pregnancy

    Adverse Pregnancy Outcomes and

    Relationship to HIV InfectionPregnancy Outcome Relationship to HIV Infection

    Spontaneous abortion Limited data, but evidence of possible increasedrisk

    Stillbirth No association noted in developed countries;evidence of increased risk in developingcountries

    Perinatal mortality No association noted in developed countries, butdata limited; evidence of increased risk indeveloping countries

    Newborn mortality Limited data in developed countries; evidence ofincreased risk in developing countries

    Intra-uterine growthretardation

    Evidence of possible increased risk

    Anderson 2001.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    6/29

    6HIV and Pregnancy

    Adverse Pregnancy Outcomes and

    Relationship to HIV Infection (continued)Pregnancy Outcome Relationship to HIV Infection

    Low birth weight Evidence of possible increased risk

    Preterm delivery Evidence of possible increased risk, especially w/more advanced disease

    Pre-eclampsia No data

    Gestational diabetes No data

    Amnionitis Limited data; more recent studies do not suggestan increased risk; some earlier studies foundincreased histologic placental inflammation,particularly in those with preterm deliveries

    Oligohydramnios Minimal data

    Fetal malformation No evidence of increased risk

    Anderson 2001.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    7/29

    7HIV and Pregnancy

    Mother-to-Child Transmission

    25 35% of HIV positive pregnant mothers will pass HIV to theirnewborns

    In the absence of breastfeeding:

    30% of transmission in utero

    70% of transmission during the delivery

    Meta-analysis showed 14% transmission withbreastfeeding and 29% transmission with acute maternal

    HIV infection or recent seroconversion

    DeCock et al 2000; Dunn et al 1992; WHO/UNAIDS 1999.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    8/29

    8HIV and Pregnancy

    Risk Factors for Mother-to-Child

    TransmissionViral load (HIV-RNA level)

    Genital tract viral load

    CD4 cell countClinical stage of HIV

    Unprotected sex with multiplepartners

    Smoking cigarettes

    Substance abuseVitamin A deficiency

    STDs and other coinfections

    Antiretroviral agents

    Preterm deliveryPlacental disruption

    Invasive fetal monitoring

    Duration of membrane rupture

    Vaginal delivery vs. cesarean

    sectionBreastfeeding

    Anderson 2001.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    9/29

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    10/29

    10HIV and Pregnancy

    HIV Testing during Pregnancy

    Advantages:

    Possible treatment of mother

    Reduce risk of mother-to-child transmissionFuture family planning issues

    Precautions against further spread

    If negative, advise about HIV prevention

    Counseling is important!

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    11/29

    11HIV and Pregnancy

    Antenatal Care

    Most HIV-infected women will be asymptomatic

    Watch for signs/symptoms of AIDS and pregnancy-relatedcomplications

    Unless complication develops, no need to increase number ofvisits

    Treat STDs and other coinfections

    Counsel against unprotected intercourse

    Avoid invasive procedures and external cephalic versionGive antiretroviral agents, if available

    Counsel about nutrition

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    12/29

    12HIV and Pregnancy

    Antiretrovirals

    Zidovudine (ZDV):

    Long course

    Short courseNevirapine

    ZDV/lamivudine (ZDV/3TC)

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    13/29

    13HIV and Pregnancy

    ZDV Perinatal Transmission Prophylaxis

    Regimen: ACTG 076 TrialAntepartum Initiation at 14 34 weeks gestation and continued

    throughout pregnancyPACTG 076 regimen: ZDV 5 times daily

    Acceptable alternative regimen: ZDV 2 or 3 timesdaily (depending on dose)

    Intrapartum During labor, ZDV IV over 1 hour, followed by acontinuous infusion of IV until delivery

    Postpartum Oral administration of ZDV to newborn for first 6

    weeks of life, beginning at 8 12 hours after birth

    Anderson 2000.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    14/29

    14HIV and Pregnancy

    Intrapartum vs. Postpartum Regimensfor HIV-Infected Women in Labor with

    No Prior Antiretroviral TherapyDrug

    RegimenMaternal

    IntrapartumNewborn

    PostpartumData on

    Transmission

    Nevirapine One oraldose at onsetof labor

    One oral dose atage 48 72 hours (ifmother receivednevirapine < 1 hourbefore delivery,newborn given oralnevirapine as soonas possible afterbirth and at 48 72hours)

    Transmission at 6weeks 12% withnevirapinecompared to 21%with ZDV, a 47%(95% CI, 20 64%)reduction

    Anderson 2001.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    15/29

    15HIV and Pregnancy

    Intrapartum vs. Postpartum Regimensfor HIV-Infected Women in Labor with

    No Prior Antiretroviral Therapy (contd.) Drug

    RegimenMaternal

    IntrapartumNewborn

    PostpartumData on

    Transmission

    ZDV/3TC ZDV orally atonset of laborfollowed bydose orallyevery 3 hoursuntil deliveryAND

    3TC orally atonset of labor,followed bydose orallyevery 12 hours

    ZDV orally every12 hours

    AND

    3TC orally every12 hours for 7days

    Transmission at6 weeks 10%with ZDV/3TCcompared to17% withplacebo, a 38%reduction

    Anderson 2001.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    16/29

    16HIV and Pregnancy

    Intrapartum vs. Postpartum Regimensfor HIV-Infected Women in Labor with

    No Prior Antiretroviral Therapy (contd.) Drug

    RegimenMaternal

    IntrapartumNewborn

    PostpartumData on

    Transmission

    ZDV IV bolus, followedby continuousinfusion of everyhour until delivery

    Orally every 6hours for 6weeks

    Transmission10% with ZDVcompared to27% with no ZDVtreatment, a 62%(95% CI, 19-82%)reduction

    Anderson 2001.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    17/29

    17HIV and Pregnancy

    Intrapartum vs. Postpartum Regimensfor HIV-Infected Women in Labor with

    No Prior Antiretroviral Therapy (contd.) Drug

    RegimenMaternal

    IntrapartumNewborn

    PostpartumData on

    Transmission

    ZDV andNevirapine

    IV bolus, thencontinuousinfusion untildeliveryANDNevirapine singleoral dose atonset of labor

    Orally every 6hours for 6weeksANDNevirapine singleoral dose at age48 72 hours

    No data

    Anderson 2001.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    18/29

    18HIV and Pregnancy

    Obstetric Procedures

    Because of increased fetal exposure to infected maternal bloodand secretions, increased transmission may come from:

    Amniotomy

    Fetal scalp electrode/sampling

    Forceps/vacuum extractor

    Episiotomy

    Vaginal tears

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    19/29

    19HIV and Pregnancy

    Delivery: Cesarean vs. Vaginal Birth

    Risk of mother-to-child transmission increased 2% each hourafter membranes have been ruptured

    Cesarean section before labor and/or rupture of membranesreduces risk of mother-to-child transmission by 50 80%compared with other modes of delivery in women on noantiretroviral therapy or on ZDV alone

    No evidence of benefit with cesarean section after onset oflabor or membranes have been ruptured

    Cesarean section, however, increases morbidity and possiblemortality to mother

    Give antibiotic prophylaxis for cesarean section in HIV-infectedwomen

    International Perinatal HIV Group 1999;Semprini 1995.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    20/29

    20HIV and Pregnancy

    Recommended Infection

    Prevention PracticesNeedles:

    Take care! Minimal use

    Suturing: Use appropriate needle and holderCare with recapping and disposal

    Wear gloves, wash hands with soap immediately after contactwith blood and body fluids

    Cover incisions with watertight dressings for first 24 hours

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    21/29

    21HIV and Pregnancy

    Recommended Infection

    Prevention Practices (continued)Use:

    Plastic aprons for delivery

    Goggles and gloves for delivery and surgeryLong gloves for placenta removal

    Dispose of blood, placenta and waste safely

    PROTECT YOURSELF!

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    22/29

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    23/29

    23HIV and Pregnancy

    Breasfeeding Issues

    Warmth for newborn

    Nutrition for newborn

    Protection against other infectionsSafety unclean water, diarrheal diseases

    Risk of HIV transmission

    Contraception for mother

    Cost

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    24/29

    24HIV and Pregnancy

    Breastfeeding Recommendations

    If the woman is:

    HIV-negative or does not know her HIV status, promoteexclusive breastfeeding for 6 months

    HIV-positive and chooses to use replacements feedings,counsel on the safe and appropriate use of formula

    HIV-positive and chooses to breastfeed, promote exclusivebreastfeeding for 6 months

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    25/29

    25HIV and Pregnancy

    South Africa Breastfeeding Trial:

    Objective and DesignObjective: To assess whether pattern of breastfeeding is acritical determinant of early mother-to-child transmission ofHIV

    549 HIV-infected women studied

    Compared newborns at 3 months that had been:

    Exclusively breastfed

    Breastfed and formula-fed

    Never breastfed

    Coutsoudis et al 1999.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    26/29

    26HIV and Pregnancy

    South Africa Breastfeeding Trial:

    Results and ConclusionRisk of transmission in:

    156 newborns who were never breastfed: 18.8% (95% CI12.6 24.9)

    288 newborns who were breastfed and formula fed: 24.1%(95% CI 19.0 29.2)

    103 newborns who were exclusively breastfed: 14.6 (95% CI7.7 21.4)

    Conclusion: Newborns who were exclusively breastfed for atleast 3 months did not have any excess risk of HIV infectioncompared to newborns who were not breastfed

    Coutsoudis et al 1999.

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    27/29

    27HIV and Pregnancy

    Conclusion

    Voluntary counseling and testing

    Antenatal, intrapartum and postpartum care to mother candecrease risk of mother-to-child transmission

    Antiretroviral therapy can also reduce risk of transmission

    Newborn care: Feeding

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    28/29

  • 8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission

    29/29

    29HIV and Pregnancy

    References (continued)

    International Perinatal HIV Group. 1999. The mode of delivery and the riskof vertical transmission of human immunodeficiency virus type 1. N Engl JMed 340(14): 977 987.Mandelbrot L et al. 1996. Obstetric factors and mother-to-childtransmission of human immunodeficiency virus type 1: The Frenchperinatal cohorts. Am er J Obs te t Gynecol 175(3 pt 1): 661 667.Semprini AE et al. 1995. The incidence of complications after cesareansection in 156 women. AIDS 9:913 917.Shaffer N et al. 1999. Short-course ZDV for perinatal HIV-1 transmission inBangkok, Thailand: A randomized controlled trial. Lancet 353: 773 780.

    Sperling RS et al. 1996. Maternal viral load, ZDV treatment, and the risk oftransmission of HIV type 1 from mother to infant. N Engl J Med 335(22):1621 1629.UNICEF/UNAIDS/WHO Technical Consultation on HIV and Infant Feeding.1998. HIV and Infant Feeding: Implem entation o f Guidelines . WHO:Geneva.World Health Organization (WHO)/Joint United Nations Programme onHIV/AIDS (UNAIDS). 1999. HIV In Pregn ancy : A Review . WHO/UNAIDS:

    Geneva


Recommended